The biotechnological developments of today have caused extremely important issues about ethics and human rights to be addressed in the field of healthcare while accelerating discussions on issues such as the disclosure, confidentiality, and sharing of genetic information. Genetic information, aside from contributing to scientific advances, contains numerous threats to economic, social, and work life. In this process, one of the most important issues coming to the fore has been genetic discrimination in working life, along with the widespread use and acceptance of genetic tests in the society. While certain genetic features are primarily linked to racial and ethnic groups, "genetic requirements" have emerged as an objective criterion in discrimination at the workplace. One branch of the genetic tests applied to the workplace constitutes professional diseases and occupational health issues. However, the issue of whether employers imply the tests are necessary because of business is a subject open to debate. The purposes of this study are to establish a descriptive framework of genetic discrimination within the scope of gene, ethics, human rights, and work life, to create awareness in the context of genetic discrimination practices and their legal dimension, and to develop a model of proactive measures against genetic discrimination as a type of discrimination that may come to the fore in Turkey along with the widespread use of cheap and accessible genetic tests.
Biotechnological developments have various costs and benefits, and studies on genetics have currently gained momentum. These studies, on the one hand, have become a guiding and important tool for the early diagnosis and treatment of inherited diseases; on the other hand, they have caused certain at-risk individuals to encounter discriminatory practices at work and in health insurance (Demir, 2013, p. 318) .
One can address the subject ethically in two dimensions. The first of these is the problems that people who have had genetic testing experience in their professional life, and the second is the question of whether the professionals who perform genetic testing and stem cell research act within the framework of professional ethical principles or monitor this fact. However, this study will evaluate the subject only in the context of discrimination at the workplace. The purpose and subject of this study is how to protect the privacy of an individual's genetic information during the storage, sharing, and utilization of genetic information, which is highly complex and threatening in nature, by examining discrimination at the workplace (in job applications and the employment process) and evaluating this discrimination in terms of its possible results and ethicality.
Genetic Information, Sharing, and Ethics

Modern Biotechnology: Genetic Technology and Information
The foundations of the techniques of modern biotechnology are based from the 1970s (Üstün & Demirci, 2016, p. 158) . The rise of genetic research in the developmental process of biotechnology and the bio-industry corresponds to processes known as the Third Industrial Revolution together with the Fourth Industrial Revolution (Industry 4.0) pointing to the era of big data, which is conceptualized to have begun in 2011 (Alçın, 2016, p. 19) . Schwab (2016) stated that this process will change everyone's life-style, work life, and personal relationships radically. Whether the Fourth Industrial Revolution will bring chemical, biological, and nuclear wars along with it has been recently discussed (Karademir, 2016, p. 1) . These concerns have been affected by the ability to obtain information on genetic uncertainties regarding storing, sharing, and using this information and the possibility that genetic analytical tests will serve commercial purposes (Evsel, 2007, p. 139 ).
According to Harris (2001) , the bioethical concept, which was brought about by these aforementioned developments, is a field close to medical ethics in a sense, and is basically the product of radical transformations in the more traditional area of medical ethics (moral philosophy; Harris, 2001 , as cited in Göçer, 2011 . Rifkin (1998) , in his book The Biotech Century, has replaced oil with genetics and identified DNA as the raw material while comparing the industrial and biotechnological industries.
The Human Genome Project (HUGO), which began in 1990 and has the ultimate goal of combining integrated yet independent research projects (Kaufmann, 1998, p. 395) , has been at the beginning of extensive research and discoveries in genetics (Boehner, 2000, p. 1) . In the description of the Human Genome Project, which occurred in 2002, the general populace's genetic data (including the gene chain) was stated to be considered "public property" and may be used without endangering others (Knoppers & Joly, 2007, p. 286) . However, medical information is one of the most sensitive types of information.
Genetic science can be considered as a 20th-century extension of the secularist science that had developed in parallel with the birth of the absolute dualism between matter and spirit caused by the Cartesian Revolution in the 17th century (Al-Attas, 2016, p. 60) . Information, an existential possession without material features, brings about some difficulties related to its own area of control. Genetic information, whose sharing and limits of sharing are discussed, is essentially a password consisting of four chemical letters, and scientist have expressed that this password is transferred from generation to generation, from father and mother to the children (Gültekin & Gökçümen, 2009, p. 51) .
The issue of determining who is responsible for protecting genetic information is important. In many professions, managers responsible for worker health, health benefits, and security programs are also held responsible for the protection of genetic information. And the issue on what the criteria are for accessing this information will depend on cases concerning public safety and remains generally uncertain (Silvers & Stein, 2002 , pp. 1345 -1346 .
Today has numerous banks where genetic materials can be found, and thousands of blood and tissue specimens are collected in research laboratories every year and stored in archives. Technological developments have offered an extremely rich collection of DNA samples to states and governments, and the profiles of many people have also been created in accordance with this information (Weiss, 2004) . The preservation of genetic tissue is considered a regular part of clinical tests and observation-based studies (Çarin, 2005, p 
. 1).
A database of medical information created by the Icelandic Government in 1998 for the purpose of covering the entire population (290,000 people) was purchased, in 2000 by DeCODE Genetics, a biotechnology company, within the framework of the right to manage and use it for a 12-year period (Özbaş-Gerçeker, Oğuzkan-Balcı, & Pehlivan, 2008, p. 37) . In this context, biobanks have been gathering data for a long time, even in small numbers. However, the expansion of these banks to a national scale took place after the establishment of the Icelandic genetic database. The facts that a portion of bio-banks have collected tissue samples and information from children and their parents, that children offer an unprotected research population, and that parents have given their right of consent (consent obtained by being previously informed) have led to an increase in specific concerns (Gurwitz, Fortier, Lunshof, & Knoppers, 2009, p. 818) .
Information Sharing and Ethics
In genetic studies where people have been at the forefront like this, the need to comply with principles specific to this subject, as well as with the existing ethical principles of research and science, has been addressed in studies from committees appointed by international agencies (United Nations Educational, Scientific, and Cultural Organization [UNESCO], American National Bioethics Advisory Commission, and the National Institute of Health). In these committees' studies, the importance of paying attention to three ethical concerns and ethical rules were emphasized. The rules of ethics should be addressed in terms of: the people who participate in genetic research, the ethical issues that must be taken into account when determining genetic research topics and objectives, and the individuals who will benefit from the results of research topics (Tazebay, 2002, p. 51 ).
Confidentiality of genetic information is extremely important. If confidentiality has not been ensured, negative consequences such as discrimination at the workplace and in the insurance field may occur. Employers avoid hiring individuals with certain hereditary diseases based on genetic testing, while insurers may rearrange insurance costs based on these genetic test results (Yunta et al., 2005, p. 245) . Cheaper and easier test implementation will inevitably bring the spread of genetic discrimination all around the world among employers and insurers (Kaufmann, 1998, p. 394) .
Society perceives genetic information as private information, and many people believe that genes carry their own unique identity. The misuse of genetics in such processes as the Eugenics Movement, which has expressed using the evolutionary selection process for the purposes of developing a specific genetic race or nation (Erbaş & Evsel, 2012, p. 341) , has strengthened society's interest in the subject.
The boundary of ethical responsibility for sharing information may vary proportionally with freedom and with the awareness of good and bad (Töle, 2005, p. 14) . The course of the relationship between freedom and responsibility is also a conscientious and internal determinant that should be supported through legal grounds for the future of genetic information sharing.
In order not to impede scientific progress, undesired boundaries must be identified first, and any risks that may arise in gene technology should be removed. Therefore, evaluating gene technology in terms of ethics, the possible consequences (Üstün & Demirci, 2016, p. 161) , and the crisis scenarios should be disclosed.
Genetic Determinism and Human Rights
According to Lewontin (1994, pp. 23-41) , ideas that claim differences among people could turn into status differences. They constitute the ideological skeleton of biological determinism, and a biological polish is applied onto the uneven structures in society (as cited in Çankaya, 2014, p. 312) .
Genetic determinism, which is at the point of converting genetic differences to differences in status, has carried discriminatory practices and social Darwinism of the 19th century into the 20th century (Çankaya, 2014, pp. 314-315) . In the framework of genetic determinism, those who treat genetics as a reductionist science can regard individuals with superior intelligence as superior people, and the social inequality resulting from this situation, which is regarded as natural inequality, is also thought to be the expected result. Thus, genetic determinism's search for legitimacy has turned into an ideology that involves inequality and potential totalitarianism (p. 313).
The biological polish that is applied over unequal structures in society, separating discrimination from its categorical view and presenting genetic information as an objective criterion, are not sufficient to separate genetic discrimination from being identified as discrimination. In this context, raising awareness of genetic discrimination as a kind of racial, ethnic, or sexual discrimination becomes important. Essentially, genetic realities can also have certain tendencies in connection with race and ethnicity. This shows the potential for genetic discrimination to include basic elements such as racial, ethnic, or sexual discrimination.
Genetic Discrimination at the Workplace
Genetic information, having easily misunderstood features that can legitimize racial-ethnic samples and manipulation, carries the risk of forming a potential biological lower class over individuals' inherited and hidden illnesses (Kaufmann, 1998, p. 419) and brings the reality of being fired or discriminated against at the workplace to an employee or potential employee (Kaufmann, 1998, p. 395) . Making sure that individuals' genetic information are used by employers, insurance companies, and governments accurately and equitably is impossible (Silvers & Stein, 2002 , pp. 1345 -1348 .
Discrimination refers to the exclusion of individuals or groups in thought or deed whereby they face different types of applications (Göregenli, n.d., . Discrimination can occur in all social systems, sometimes at an organizational level, sometimes at a business or professional level, and sometimes at the workplace (BilirGüler, 2005, p. 34) . Following biotechnological developments, genetic discrimination has been added as a new dimension to the subject of discrimination. By its most basic definition, genetic discrimination can be expressed as when an individual with different genes that increase the risk of illness receives different treatment from employers or insurance companies. Genetic discrimination is a versatile, moral, psychological, and legal phenomenon that is defined as being treated differently based on real or hypothetical genetic characteristics of asymptomatic individuals or their relatives (Otlowski, Taylor, & Bombard, 2012, p. 433) . Discrimination, through its genetic dimensions, differs from other types of discrimination such as racial, religious, ethnic, national, sexual, and so on because it relates to the health of the individual.
The growth of genetic discrimination arises from the results of biological tests and certain biological features and from general to specific correctness is one of the most recent extensions in the growing fight against discrimination (Akbulut, 2012, p. 150) in the West, especially the US and in developed and biotechnologically advanced countries.
Genetic discrimination at the workplace can be interpreted by two separate theories: the disparate impact theory and the disparate treatment theory (Green, 2003, p. 111) .The most important element in the disparate treatment theory, which is the most obvious form of discrimination, is discrimination by the employer due to an individual's specific characteristic. Despite the fact that many genetic traits are linked to race and ethnicity, a genetic distinction emerges in this theory as an objective criterion in discrimination. An employer who refuses to recruit any individual who has a certain genetic indicator does not discriminate against members of a single race because numerous genetic diseases go beyond racial boundaries. For this reason, a claim of genetic discrimination within the framework of disparate treatment theory would probably fail; the employer's intent to discriminate would be impossible to prove. The disparate impact theory, in order to create claims of different effects, depends on the proof that genetic screening creates a discriminatory impact on groups protected by law. Here, proving whether screening is a work-related job requirement becomes important. While genetic screening as a work requirement concerns whether the individual applying for the job is capable of performing work-related functions, genetic screening as work-related has a narrower scope and indicates whether the criteria for hiring employees logically connects to the demands of the work. However, many reasons that employers put forward for needing genetic testing are insufficient for consideration as a job requirement. In addition, as genetic tests determine the potential future of a disease, not the current situation, future and unspecified threats are insufficient to reach the level of being a job requirement (Kaufmann, 1998, pp. 420-423) .
Two types of genetic testing methods are applied at the workplace: genetic screening and genetic monitoring. Genetic screening is a one-time test applicants take in order to determine their genetic predisposition to certain diseases (Kaufmann, 1998, pp. 397-399) . Genetic screening, with its accompanying misunderstandings, mistrust, and fears, has been subjected to severe restrictions under the Genetic Information Nondiscrimination Act of 2008 (Brandt-Rauf, Borak, & Deubner, 2015, p. 17). Genetic monitoring refers to a periodic follow-up of individuals to assess changes that may have occurred in their DNA. The reasons for genetic observation are to identify risks associated with certain toxins, increase safe areas at the workplace, and identify workplace toxins that were previously unknown (Kaufmann, 1998, p. 400) . Genetic monitoring differs from genetic screening, which presents an instantaneous snapshot, in the sense that it covers a timeframe (Schwartz, Luikart, & Waples, 2006, p. 25) .
In fact, when employers are recruiting, they have a right to perform medical or genetic tests for candidates' occupational health, occupational diseases, and qualifications. However, the problem is whether an employer uses these tests in a discriminatory way (Kaufmann, 1998, pp. 400-409) .
Genetic Discrimination Practices
Information on whether genetic discrimination happens or the extent to which it has happened is determined from the results of studies carried out at various times. The current number of genetic discrimination cases varies according to who is being asked and many other factors.
According to a study by the Office of Technology Assessment (OTA, 1983) in 1982 in the US, in which 366 of the 500 largest industrial companies participated, genetic testing is used for employment-related purposes. According to another OTA study in 1989, employees are subjected to genetic testing (Kaufmann, 1998, p. 394) , and according to another study in 2000, genetic testing is planned as a pre-condition of employment (Krumm, 2002, p. 495) . In another study conducted by the American Management Association (1997), employers were found to lead in the opinion that genetic tests should be applied. According to a survey conducted on almost 1,000 atrisk people due to their genetic structure, more than 22% stated having been subject to discrimination because of being at risk for a genetic disorder (Geller, 1996) . The US Bureau of Labor has considered genetic information to be an extremely serious issue at the workplace because of the private individual data it contains (US Department of Labor, 1998).
In addition to the data that has been collected as a whole, individual cases may also be reflected in academic studies or in the media. In individual cases, information can be obtained prior to discrimination through various channels (an invoice or a sincere confession) outside of the legal protection system so that legal reflections can also differ.
Studies also exist that investigate the attitudes of the population towards genetic studies. For example, in one study investigating the public's perception regarding the use of genetic analysis tests in Turkey, 61.7% of respondents agreed with the idea that these tests could be used for discrimination at the workplace (Evsel, 2007, pp. 130-136) . In research carried out on American individuals in Philadelphia of African and Caucasian origins (Peters, Rose, & Armstrong, 2004, p. 363) , 17% of respondents answered that genetic tests could be used in order to discriminate in the workplace (Evsel, 2007, p. 135) .
The Legal Dimension of Genetic Discrimination
The legal dimension of genetic discrimination varies in different parts of the world. In the US, the homeland of biotechnological developments, citizens are protected according to the Americans with Disabilities Act (ADA), both individually and in situations of genetic discrimination during the employment process; one interpretation of the Equal Employment Opportunity Commission (EEOC) also exists in accordance with the ADA. In addition to the legal protections such as Civil Rights Act and the Occupational Safety and Health Administration (OSHA) many individual states have been trying to control genetic tests within their borders also with their own regulations (Kaufmann, 1998, pp. 395-396) . However, the Genetic Information Nondiscrimination Act of 2008 prohibits genetic discrimination both in the fields of employment and health insurance (Vasichek, 2009, p. 28) . The state legislations in force, based mainly on the precedents of privacy, have antidiscriminatory provisions spread inside them. For example, the first state legalizing an anti-genetic discrimination law (North Carolina), has prevented discrimination in employment based on sickle-cell anemia (Silvers & Stein, 2002 , pp. 1358 -1359 .
Former US Presidents George W. Bush and Obama exhibited anti-genetic discrimination attitudes in employment and supported legislation on this subject (Boehner, 2000, p. 1; Obama-Care No Discrimination, 2014) . More time is needed to observe how the new President Trump's otherizing discourses will be reflected in genetic discrimination. Using language that covers employer-use of genetic information in legislation is just as important as in presidential speeches to prevent genetic discrimination (Rachinskyt, 2000, p. 588) .
Canada is the only country among the G7 countries (US, Canada, UK, Japan, France, Italy, Germany) that does not have a special system of protection for genetic testing results and, therefore, protection against genetic discrimination (Baranyai, 2017, p. 1) . Canadians who have been subjected to genetic testing, according to the law, can be forced by insurance companies and employers to disclose their test results (The Center for Israel and Jewish Affairs, 2015). However, the Canadian government seems ready to fix this mistake and appears cautious (Baranyai, 2017, p. 1) .
In the European Union, Article 21 on topic of "Non-discrimination" in the "Charter of Fundamental Rights," guarantees every individual's freedom of religion and conscience (Yıldırım, 2016 (Yıldırım, , p. 1021 . The declaration, Bioethics and the Universal Declaration of Human Rights, prepared with regard to genetic studies in 2003 by UNESCO (2003) was internationally accepted as a standard document two years after its publication and recognition by many countries (Gökçümen & Gültekin, 2009, p. 25 (Evsel, 2007 , p. 135) as Law No. 5013 (Ministry of Health, 2017 Göçmen, 2016) . Article No. 11 of the Human Rights and Biomedicine Convention has the same standing as laws (Üstün & Demirci, 2016, p. 161) and includes genetic discrimination in employment and at the workplace under the title of "Non-discrimination." Items 12, 13, and 14 of Article 11 include medical ethics and ethical subjects (Ministry of Health, 2017) . No legal arrangements exist yet in Turkey that are specific to biobanking (Emir, 2013, p. v) .
The trend of legal developments in the direction of positioning the status of the human genome as a patentable subject by removing it from the area of Humanity's Common Heritage should be kept in mind in regard to the possible consequences of the developments in this subject (Dülger, 2014, p. 511) .
Possible Results of Genetic Discrimination and Recommendation for a Model of Proactive Measures
To summarize the potential consequences of possible genetic discrimination at the workplace, firstly refusing to employ at-risk individuals in the positions or organizations where they want to work because of genetic test results may lead to the deterioration of the quantitative and qualitative balance of supply and demand in labor and cause unemployment. Unemployment can bring individuals and their families to become dependents, and this can also affect social welfare expenditures. Individual efficiency and success will also be affected by this situation. The possibility that working individuals will have problems being discharged from their duties or with subjects related to promotion according to the results of genetic tests may increase the individual levels of stress and distraction, thus increasing work accidents. Genetic tests can put existing employees in a situation where they'll become insensitive or reluctant to change positions. The fear of becoming unemployed may discourage individuals from genetic testing and thus deter them from receiving diagnosis and treatment for certain diseases. Scientific findings that state that an increase in the frequency of genetic diseases especially in certain groups (for example, women or individuals over forty) may lead these groups to become black-listed in the labor market. Finally, because the burden of the labor courts will increase due to genetic discrimination cases, there will also be loss of time and effort.
However, one also needs to consider the situation of people who currently work or go to work in strategic positions and institutions. For example, employing a pilot who intentionally crashes a plane because of psychological problems may cost the lives of hundreds of people (British Broadcasting Company, 2015) . This issue can therefore be addressed in the context of proactive crisis management. As a matter of fact, determining the lines of discrimination and of crisis management and focusing on intersecting areas are very important.
In terms of crisis management, the proactive model is defined as "the lack of being able to interfere with threatening conditions," and means developing different alternatives prior to the formation of a crisis so as to prevent it (Tağraf & Arslan, 2003, pp. 149-150) . In this context, a proactive model of crisis management can be adopted as a precaution through government policies within the framework of combating genetic discrimination.
Employers who ask applicants for genetic testing or who as current employees to perform genetic monitoring will perhaps be a topic that can be added to Turkey's list of social problems in the near future. In this context, before placing the issue of discrimination on the agenda, a Proactive Measures Model in the fight against genetic discrimination still needs to be developed and assessed by authorities with reasonable provisions.
In the process of preventing genetic discrimination, Fukuyama (2003) explained that existing institutions should be changed or transformed. According to Fukuyama, regulatory powers can be delegated to pre-existing institutions or advisory bodies (e.g., Recombinant DNA Advisory Committee) or creating new institutions can be considered if necessary. However, on the issue of adding additional bureaucratic layers to existing institutions, one shouldn't be too pushy (as cited in Evsel, 2007, p. 132) .
Based on this response, one can propose establishing a Board of Proactive Measures for Genetic Discrimination in Turkey because the issue of genetic information and the use of this information at the workplace involve greater complexity than existing legal regulations. This board may be effective at inspecting research projects' and genetic applications' compliance with the basic values of ethics and human rights, as well as in identifying national needs in this area. The Board's great representational capacity is important for addressing the issue with a full-spectrum perspective that involves all related views. Board members should evaluate each scenario for possible genetic discrimination issues. In this context, the proactive method, a method of crisis management, would be useful when adapting genetic discrimination issues to the political level.
However, one should note that the presence and adoption of ethical principles on this topic is more effective than legal protection (Arslan, 2005, p. 112) . In cases where ethical principles do not guide decisions, legal regulations may be insufficient at protecting all employees against all scenarios (Murry, Wimbush, & Dalton, 2001, p. 365) .
What is expected from states, employers, insurance companies, and other individuals related to this issue is the proper and just use of genetic information. Otherwise, individuals who have hereditary genetic diseases will unavoidably be exposed to intrusive and damaging practices similar to racial discrimination.
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